Literature DB >> 8775041

Clinical study on prognosis of metastatic prostate cancer based on extent of disease on pretreatment bone scintigraphy.

H Fuse1, I Mizuno, T Yokoyama, M Sakamoto, T Katayama.   

Abstract

The pretreatment bone scintigrams of 58 patients with prostate cancer with bone metastasis were reviewed and the prognostic value of the initial extent of bone involvement was compared with that of other pretreatment characteristics. The extent of bone metastasis revealed by the scan was related to survival. The serum level of alkaline phosphatase at pretreatment and pathological grade also had some predictive value. Although the pathological grade of primary tumours was related to prognosis, the survival of patients with the same histological grade differed according to the initial extent of disease; patients with extensive disease along with raised serum alkaline phosphatase (twice or more as high as the cut-off value) had poorer prognosis than did those with lower alkaline phosphatase or smaller extent of disease. The extent of bone involvement in combination with serum alkaline phosphatase level therefore apparently has higher prognostic value than does disease extent alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8775041     DOI: 10.1007/bf02564743

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Carcinoma of the prostate: metastases, therapy and survival; a statistical analysis of five hundred cases.

Authors:  L W McCREA; L KARAFIN
Journal:  J Int Coll Surg       Date:  1958-06

2.  Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.

Authors:  M S Soloway; S W Hardeman; D Hickey; J Raymond; B Todd; S Soloway; M Moinuddin
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

3.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

4.  An exponential model relating censored survival data and concomitant information for prostatic cancer patients.

Authors:  D P Byar; R Huse; J C Bailar
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

5.  Prostate-specific acid phosphatase versus acid phosphatase in monitoring patients with prostate cancer.

Authors:  C S Killian; F P Vargas; N H Slack; G P Murphy; T M Chu
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: a preliminary report.

Authors:  C B Brendler; J T Isaacs; A L Follansbee; P C Walsh
Journal:  J Urol       Date:  1984-04       Impact factor: 7.450

7.  Histologic grading of prostatic carcinoma.

Authors:  A Böcking; E Sinagowitz
Journal:  Pathol Res Pract       Date:  1980       Impact factor: 3.250

8.  Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma.

Authors:  A Drelichman; D A Decker; M Al-Sarraf; V K Vaitkevicius; J Muz
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

9.  Quantitative radiology for staging and prognosis of patients with advanced prostatic carcinoma. Correlations with other pretreatment characteristics.

Authors:  J A Hovsepian; D P Byar
Journal:  Urology       Date:  1979-08       Impact factor: 2.649

10.  Grading of prostatic cancer (I): An analysis of the prognostic significance of single characteristics.

Authors:  F H Schroeder; J H Blom; W C Hop; F K Mostofi
Journal:  Prostate       Date:  1985       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.